Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Hisoar Pharma Raises $79 Million for Capital Projects

publication date: Feb 25, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Zhejiang Hisoar Pharmaceutical will raise 520 million RMB ($79 million) in a private placement, issuing 25 million shares at 20.92 RMB ($3.18) each. Hisoar’s Chairman, Li Wei, will buy at least 10% of the offering. The great majority of the proceeds is earmarked for two major capital projects. Hisoar said the projects will add around 1.2 billion RMB ($182.5 million) in annual sales, once they are completed. More details....

Stock Symbol: (SHE: 002099)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners